JDD April 2023 Issue Highlights
The April issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, features, and case reports, with topics ranging from hormonal therapy in hidradenitis suppurativa, private equity in dermatology, vitiligo and its associated comorbidities, novel topical products for facial dyschromia, and many more. Check out this month’s issue highlights straight …
The April issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, features, and case reports, with topics ranging from hormonal therapy in hidradenitis suppurativa, private equity in dermatology, vitiligo and its associated comorbidities, novel topical products for facial dyschromia, and many more. Check out this month’s issue highlights straight … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Heather Woolery-Lloyd, who is board certified in both dermatology and lifestyle medicine. Watch as she shares the six major pillars of lifestyle medicine, and which dermatologic conditions are shown to be influenced by lifestyle factors. You may change how you counsel your patients after watching this video!
F … 
INTRODUCTION
Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib … 
Allure recently posted a first-person account of acne excoriée. How can dermatologists best counsel patients who pick their acne lesions, and what tools can help address the urge to pick?
For expert advice, I reached out to dermatologist and clinical psychologist Rick Fried, MD, PhD, clinical director of Yardley Dermatology Associates and Yardley Clinical Research Associates in Yardley, Pa.
… 
Before we dive into our discussion, let’s outline the Guideline-Based Approach to Treatment Selection.
The International Psoriasis Council has divided psoriasis treatment classification into 2 groups:
Patients who are a candidate for topical therapy, or
Patients who are a candidate for systemic therapy
Candidates for systemic therapy must meet at least 1 of the following … 